Craneware (LON:CRW) Earns Buy Rating from Shore Capital

Key Points

• Shore Capital has reiterated a "buy" rating for Craneware's stock (LON:CRW) with a price target of GBX 2,850, indicating a potential upside of 14% from its previous close.
• Other analysts, including Berenberg Bank and Peel Hunt, also support a "buy" rating for Craneware, with price targets ranging from GBX 2,871 to GBX 2,900.
• Craneware's stock opened at GBX 2,500, with a market capitalization of £885.25 million and significant fluctuations reflected in its 52-week range of GBX 1,330 to GBX 2,580.

Craneware (LON:CRW - Get Free Report)'s stock had its "buy" rating reiterated by analysts at Shore Capital in a research report issued to clients and investors on Tuesday,Digital Look reports. They currently have a GBX 2,850 price objective on the stock. Shore Capital's target price suggests a potential upside of 14.00% from the stock's previous close.

A number of other analysts also recently issued reports on CRW. Berenberg Bank lifted their price target on shares of Craneware from GBX 2,800 to GBX 2,900 and gave the company a "buy" rating in a report on Monday. Peel Hunt reiterated a "buy" rating and issued a GBX 2,871 price target on shares of Craneware in a report on Monday. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of GBX 2,873.67.

Craneware Stock Performance

Shares of LON CRW opened at GBX 2,500 on Tuesday. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. The company has a market cap of £885.25 million, a P/E ratio of 5,882.35 and a beta of 0.28. The firm's fifty day moving average is GBX 2,277.29 and its two-hundred day moving average is GBX 2,021.57. Craneware has a 52-week low of GBX 1,330 and a 52-week high of GBX 2,580.

About Craneware

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.